Reduced sensitivity of influenza A (H5N1) to oseltamivir

Emerging Infectious Diseases

Volumn 13, Issue 9, 2007, Pages 1354-1357

  McKimm Breschkin, Jennifer L ^a   Selleck, Paul W ^a   Usman, Tri Bhakti ^b   Johnson, Michael A ^a  

^a CSIRO   (Australia)

^b Disease Investigation Centre Region IV   (Indonesia)

Author keywords

[No Author keywords available]

Indexed keywords

5 ACETYLAMINO 2,6 ANHYDRO 4 AMINO 3,4,5 TRIDEOXYGLYCEROL DEXTRO GALACTONON 2 ENOIC ACID; OSELTAMIVIR; SIALIDASE INHIBITOR; UNCLASSIFIED DRUG; VIRUS SIALIDASE; ZANAMIVIR;

ARTICLE; AVIAN INFLUENZA; CAMBODIA; CLADISTICS; DRUG SENSITIVITY; IC 50; INFLUENZA VIRUS A H5N1; NONHUMAN; VIRUS ISOLATION;

EID: 34848893293     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1309.070164     Document Type: Article

References (15)

1. De Clercq E, Neyts J. Avian influenza A (H5N1) infection: targets and strategies for chemotherapeutic intervention. Trends Pharmacol Sci. 2007;28:280-5.
2. McKimm-Breschkin JL, Blick TJ, Sahasrabudhe A, Tiong T, Marshall D, Hart GJ, et al. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. Antimicrob Agents Chemother. 1996;40:40-6.
3. Wetherall NT, Trivedi T, Zeller J, Hodges-Savola C, McKimm-Breschkin JL, Zambon M, et al. evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network. J Clin Microbiol. 2003;41:742-50.
4. Rameix-Welti MA, Agou F, Buchy P, Mardy S, Aubin JT, Veron M, et al. Natural variation can significantly alter sensitivity to oseltamivir of influenza A (H5N1) viruses. Antimicrob Agents Chemother. 2006;50:3809-15.
5. Govorkova EA, Ilyushina NA, Boltz DA, Douglas A, Yilmaz N, Webster RG. Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother. 2007;51:1414-24.
6. Hurt AC, Selleck P, Komadina N, Shaw R, Brown L, Barr IG. Susceptibility of highly pathogenic A(H5N1) avian influenza viruses to the neuraminidase inhibitors and adamantanes. Antiviral Res. 2007;73:228-31.
7. World Health Organization. Tamiflu resistance found in Egypt patients. Press release 2007 Jan 22. [cited 2007 Feb 2]. Available from http://www.emro.who.int/csr/media/pdf/ai_press_22_01_07.pdf
8. Le QM, Kiso M, Someya K, Sakai YT, Nguyen TH, Nguyen KH, et al. Avian flu: isolation of drug-resistant H5N1 virus. Nature. 2005;437:1108.
9. McKimm-Breschkin JL. Management of influenza virus infections with neuraminidase inhibitors: detection, incidence, and implications of drug resistance. Treat Respir Med. 2005;4:107-16.
10. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, et al. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature. 2006;443:45-9.
11. Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, et al. Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother. 2006;50:2395-402.
12. Zurcher T, Yates PJ, Daly J, Sahasrabudhe A, Walters M, Dash L, et al. Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in vitro. J Antimicrob Chemother. 2006;58:723-32.
13. Kiso M, Mitamura K, Sakai-Tagawa Y, Shiraishi K, Kawakami C, Kimura K, et al. Resistant influenza A viruses in children treated with oseltamivir: descriptive study. Lancet. 2004;364:759-65.
14. Smith GJ, Fan XH, Wang J, Li KS, Qin K, Zhang JX, et al. Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A. 2006;103:16936-41.
15. Varghese JN, Smith PW, Sollis SL, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL, et al. Drug design against a shifting target: a structural basis for resistance to inhibitors in a variant of influenza virus neuraminidase. Structure. 1998;6:735-46.